ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Selection of persisting clones with low BCR-ABL signaling output has been suggested as an underlying mechanism of CML persistence by preventing BCR-ABL addiction and thus TKI sensitivity [16•, 23].